Table 1.
Demographic and baseline clinical characteristics of all patients in the two groups.
|
| |||
|---|---|---|---|
| GROUP I (TIMI 3 FLOW) (N = 415) (86.5%) | GROUP II (NO-REFLOW) (N = 65) (13.5%) | P VALUE | |
|
| |||
| Age, years | 54.99 ± 9.06 | 57.52 ± 9.40 | 0.037* |
|
| |||
| Male gender, n (%) | 212 (51.1%) | 35 (53.8%) | 0.679 |
|
| |||
| Hypertension, n (%) | 154 (37.1%) | 25 (38.5%) | 0.834 |
|
| |||
| Diabetes mellitus, n (%) | 115 (27.7%) | 20 (30.8%) | 0.610 |
|
| |||
| Smoking, n (%) | 112 (27.0%) | 24 (36.9%) | 0.098 |
|
| |||
| Dyslipidemia, n (%) | 154 (37.1%) | 26 (40.0%) | 0.654 |
|
| |||
| Prior myocardial infarction, n (%) | 32 (7.7%) | 4 (6.2%) | 0.658 |
|
| |||
| Chronic kidney disease, n (%) | 51 (12.3%) | 11 (16.9%) | 0.300 |
|
| |||
| BMI, (kg/m2) | 25.03 ± 3.22 | 25.37 ± 3.08 | 0.435 |
|
| |||
| Systolic BP, mmHg | 119.6 ± 19.5 | 108.5 ± 24.3 | 0.001* |
|
| |||
| Diastolic BP, mmHg | 77.45 ± 12.7 | 74.26 ± 13.4 | 0.064 |
|
| |||
| Heart rate, (bpm) | 72.24 ± 13.3 | 74.78 ± 13.9 | 0.156 |
|
| |||
| Atrial fibrillation, n (%) | 47 (11.3%) | 13 (20.0%) | 0.049* |
|
| |||
| Killip class > 1 | 75 (18.1%) | 19 (29.2%) | 0.035* |
|
| |||
| LVEF, (%) | 45.36 ± 4.92 | 45.12 ± 5.75 | 0.725 |
|
| |||
| Non-diabetic patients with SH, n (%) | 34 (11.3%) | 17 (37.8%) | 0.001* |
|
| |||
| Non-diabetic patients with euglycemia, n (%) | 266 (88.7%) | 28 (62.2%) | |
|
| |||
| Diabetic patients with SH, n (%) | 21 (18.3%) | 9 (45.0%) | 0.008* |
|
| |||
| Diabetic patients with euglycemia, n (%) | 94 (81.7%) | 11 (55.0%) | |
|
| |||
BMI: body mass index; BP: blood pressure; LVEF: left ventricular ejection fraction; SH: stress hyperglycemia; *: significant P value.